Search
for
Sort by
Research 31–60 of 225
- The role of integrin alphavbeta6 in impaired wound healing and hair follicle regeneration
- Ultrashort peptide nanofibrous hydrogels for the acceleration of healing of burn wounds
- Biomaterials for in situ tissue regeneration: development and perspectives
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Pre-clinical non-viral vectors exploited for<i>in vivo</i>CRISPR/Cas9 gene editing: an overview
- Advancements in hydrogel-based design and applications of hair follicle organoids
- Recent advances and challenges in 3D bioprinting for skin tissue regeneration
- Development of novel wound dressing based on elastin-like recombinamers for skin regeneration
- Effect of decellularisation methods on methacryloyl-substituted placental ECM hydrogels
- Wound Healing: A Cellular Perspective
- Recent advances in electrospun nanofibers for wound healing
- Bioengineering skin using mechanisms of regeneration and repair
- Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia
- The roles of Wnt/β‐catenin pathway in tissue development and regenerative medicine
- Biomedical Applications of Layer‐by‐Layer Self‐Assembly for Cell Encapsulation: Current Status and Future Perspectives
- Demethylation of ITGAV accelerates osteogenic differentiation in a blast-induced heterotopic ossification in vitro cell culture model
- Scaffolds for epithelial and hair follicle regeneration
- Biomaterials for dermal substitutes
- Interpenetrating gelatin/sodium alginate hydrogel with controlled PRP lysate delivery for accelerating diabetic wound healing with reduced scarring
- Dermatologia e Procedimentos Estéticos Ed. XVIII
- Follikelhormone
- Proteomics Characterization of Primary Human Oral Epithelial Cells Using a Novel Culture Technique for Use in Tissue Regeneration
- Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Non-viral delivery of the CRISPR/Cas system: DNA<i>versus</i>RNA<i>versus</i>RNP
- Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
- Therapeutic Peptides in Skin and Hair Disorders
- Facile strategy for gelatin-based hydrogel with multifunctionalities to remodel wound microenvironment and accelerate healing of acute and diabetic wounds
- Alkylation of human hair keratin for tunable hydrogel erosion and drug delivery in tissue engineering applications